Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

NYSE:MAGN - New York Stock Exchange, Inc. - US55939A1079 - Common Stock - Currency: USD

13.04  +0.79 (+6.45%)

After market: 12.95 -0.09 (-0.69%)

Fundamental Rating

3

Taking everything into account, MAGN scores 3 out of 10 in our fundamental rating. MAGN was compared to 9 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of MAGN have multiple concerns. While showing a medium growth rate, MAGN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MAGN has reported negative net income.
In the past year MAGN has reported a negative cash flow from operations.
In multiple years MAGN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MAGN reported negative operating cash flow in multiple years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

MAGN's Return On Assets of -3.26% is in line compared to the rest of the industry. MAGN outperforms 44.44% of its industry peers.
The Return On Equity of MAGN (-12.12%) is worse than 66.67% of its industry peers.
With a Return On Invested Capital value of 1.08%, MAGN perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MAGN is significantly below the industry average of 7.39%.
Industry RankSector Rank
ROA -3.26%
ROE -12.12%
ROIC 1.08%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

The Operating Margin of MAGN (2.16%) is comparable to the rest of the industry.
MAGN's Operating Margin has declined in the last couple of years.
MAGN has a Gross Margin of 10.57%. This is comparable to the rest of the industry: MAGN outperforms 44.44% of its industry peers.
MAGN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.16%
PM (TTM) N/A
GM 10.57%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAGN is destroying value.
MAGN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MAGN has less shares outstanding
The debt/assets ratio for MAGN is higher compared to a year ago.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.88, we must say that MAGN is in the distress zone and has some risk of bankruptcy.
MAGN has a worse Altman-Z score (0.88) than 88.89% of its industry peers.
MAGN has a Debt/Equity ratio of 1.82. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.82, MAGN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACC0.14
WACC7.69%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.40 indicates that MAGN has no problem at all paying its short term obligations.
MAGN's Current ratio of 2.40 is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
MAGN has a Quick Ratio of 1.54. This is a normal value and indicates that MAGN is financially healthy and should not expect problems in meeting its short term obligations.
MAGN's Quick ratio of 1.54 is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.54
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MAGN have decreased strongly by -93.18% in the last year.
Looking at the last year, MAGN shows a decrease in Revenue. The Revenue has decreased by -7.09% in the last year.
The Revenue has been growing by 9.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-360%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%150.12%

3.2 Future

The Earnings Per Share is expected to grow by 39.84% on average over the next years. This is a very strong growth
Based on estimates for the next years, MAGN will show a very strong growth in Revenue. The Revenue will grow by 20.99% on average per year.
EPS Next Y-14%
EPS Next 2Y22.07%
EPS Next 3Y53.21%
EPS Next 5Y39.84%
Revenue Next Year120.68%
Revenue Next 2Y41.29%
Revenue Next 3Y27.88%
Revenue Next 5Y20.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Also next year MAGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAGN is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 53.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.07%
EPS Next 3Y53.21%

More info and screens

0

5. Dividend

5.1 Amount

MAGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNERA CORP

NYSE:MAGN (6/5/2025, 8:04:01 PM)

After market: 12.95 -0.09 (-0.69%)

13.04

+0.79 (+6.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners93.54%
Inst Owner Change0.19%
Ins Owners0.38%
Ins Owner Change31.55%
Market Cap464.22M
Analysts80
Price Target20.4 (56.44%)
Short Float %6.79%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)300%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 2.29
EV/EBITDA 11
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-1.82
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS61.45
BVpS30.7
TBVpS5.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -12.12%
ROCE 1.37%
ROIC 1.08%
ROICexc 1.17%
ROICexgc 1.63%
OM 2.16%
PM (TTM) N/A
GM 10.57%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 32.05%
Cap/Sales 2.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.54
Altman-Z 0.88
F-Score5
WACC7.69%
ROIC/WACC0.14
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-360%
EPS Next Y-14%
EPS Next 2Y22.07%
EPS Next 3Y53.21%
EPS Next 5Y39.84%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%150.12%
Revenue Next Year120.68%
Revenue Next 2Y41.29%
Revenue Next 3Y27.88%
Revenue Next 5Y20.99%
EBIT growth 1Y264.61%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y86.31%
EBIT Next 5Y61.31%
FCF growth 1Y-139.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-277.25%
OCF growth 3YN/A
OCF growth 5YN/A